RENEO PHARMACEUTICALS Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Reneo Pharmaceuticals

Access the complete profile.

Reneo Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	32541
Address	12230 El Camino Real, Suite 230 San Diego, CA 92130

Note: Revenues for privately held companies are statistical evaluations.




Reneo Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Reneo Pharmaceuticals Annual Revenue and Growth Rate

Reneo Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2019	Details in Premium Report
2018
2017
2016
2015
2014

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Reneo Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Reneo Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 21, 2020	15	50%	$95 MM
Complete list of funding rounds and total amounts in the Company Report

Reneo Pharmaceuticals's Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Reneo Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Reneo Pharmaceuticals is developing and marketing. Reneo Pharmaceuticals doesn't have any recent trademark applications, indicating Reneo Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark

Date

RENEO Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis

03/09/2018

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Reneo Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Reneo Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Reneo Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Reneo Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
NUTRITION FORMULATORS	Miramar, FL	100
XYMOGEN	Orlando, FL	99
UCKELE HEALTH & NUTRITION	Blissfield, MI	57
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
VITALABS	Mcdonough, GA	37
RTPR	Edmond, OK	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28

Nearby Competitors

These companies are similar in business line and location to Reneo Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CARDIUM THERAPEUTICS	San Diego, CA	100
GEN-PROBE	San Diego, CA	0
AJINOMOTO ALTHEA	San Diego, CA	0
ODONATE THERAPEUTICS	San Diego, CA	0
TURNING POINT THERAPEUTICS	San Diego, CA	0
IRISYS	San Diego, CA	0

Future Competition: Reneo Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Reneo Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)